Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Diabetes entities : Novo nordisk a::S save search
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial
Published: 2024-03-05 (Crawled : 10:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.33%
H: 0.46%
C: -1.27%
disease kidney risk trial diabetes flow
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
treatment glargine trial diabetes insulin
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 2.62%
H: 0.67%
C: 0.58%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.61%
C: -0.46%
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.4%
H: 0.38%
C: -2.2%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
companies diabetes study market
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
Published: 2023-08-10 (Crawled : 10:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.44%
H: 0.99%
C: -1.51%
metabolic pharma acquire diabetes living
Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency
Published: 2023-06-26 (Crawled : 07:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.25%
H: 0.29%
C: -1.41%
pharma authorization treatment hypoglycemia application diabetes
New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity
Published: 2023-04-12 (Crawled : 09:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.82%
H: 2.28%
C: 1.4%
partnership obesity biosystems therapeutics diabetes
Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial
Published: 2023-03-24 (Crawled : 16:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.26%
H: 2.45%
C: 1.85%
trial diabetes plus
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Published: 2023-03-14 (Crawled : 19:00) - biospace.com/
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.15%
H: 0.65%
C: 0.56%
diabetes living insulin
Insulin Pump Market - Global Outlook and Forecast 2023-2028: New Product Launches and Technological Advances in Diabetes Care Present Opportunities
Published: 2023-03-04 (Crawled : 04:20) - prnewswire.com
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
| Email alert
Add to watchlist
care global diabetes insulin market
Global Diabetes Care Drugs Market Report 2022: Rising Prevalence of Type-1 and Type-2 Diabetes in Children Drives Growth
Published: 2023-02-22 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.63%
H: 0.48%
C: -0.17%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.32%
H: 1.47%
C: -0.15%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
care global report children diabetes growth market
Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option for adults with type 2 diabetes
Published: 2023-01-13 (Crawled : 02:00) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.51%
H: 0.89%
C: 0.5%
rybelsus fda label approval diabetes update
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.93%
H: 3.08%
C: 3.08%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.89%
H: 1.18%
C: 0.52%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.85%
H: 0.2%
C: -0.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.62%
H: 0.54%
C: -0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
treatment patent global report growing diabetes growth market
Digital Diabetes Management Market Size to Reach USD 37.8 Billion in 2030 | Emergen Research
Published: 2022-12-21 (Crawled : 18:00) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.15%
H: 0.76%
C: 0.38%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.83%
H: 0.81%
C: -0.23%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.83%
H: 2.22%
C: 1.48%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.56%
H: 1.21%
C: 0.98%
TNDM | $35.12 0.43% 0.43% 1M
|
Health Technology
|
| O: 0.75%
H: 2.25%
C: 1.6%
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: 0.49%
H: 1.16%
C: 0.49%
DXCM | $137.86 2.88% 2.8% 3.2M
|
Health Technology
|
| O: 0.64%
H: 1.98%
C: 0.78%
management research diabetes market
Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published: 2022-10-19 (Crawled : 11:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -1.18%
H: 0.56%
C: -1.11%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.38%
H: 0.04%
C: -1.58%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.52%
H: 0.06%
C: -0.75%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.96%
H: 0.22%
C: -0.76%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
therapeutics diabetes market
Once-weekly insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in ONWARDS 5 phase 3a trial
Published: 2022-10-03 (Crawled : 12:20) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.98%
H: 1.29%
C: 0.94%
trial diabetes insulin
Insights on the Next Generation Diabetes Therapy and Drug Delivery Global Market to 2030 - Rising Incidences of Diabetes Globally and Increase in the Disposable Income is Driving Growth
Published: 2022-09-30 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.19%
H: 0.52%
C: -0.57%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.4%
H: 1.14%
C: -2.24%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.87%
H: 0.72%
C: -1.16%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.43%
H: 0.8%
C: -1.98%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
MNKD | $4.19 0.72% 0.72% 1.8M
|
Health Technology
|
| O: 0.33%
H: 7.33%
C: 3.0%
DXCM | $137.86 2.88% 2.8% 3.2M
|
Health Technology
|
| O: -0.38%
H: 2.68%
C: -1.53%
SENS | $0.433 0.7% 0.0% 1.4M
|
Electronic Technology
|
| O: -0.7%
H: 2.84%
C: -6.38%
drug global diabetes therapy growth market
More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec
Published: 2022-09-22 (Crawled : 07:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.44%
H: 0.38%
C: -0.48%
blood diabetes insulin
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.